Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Cardiovascular > Flashcards

Cardiovascular Flashcards

1
Q

Quinidine mechanism of action

A

Blocks fast Na channels in open or active state

Increases Action potential duration and effective refractory period

Blocks K channels causing prolonged repolarization

Muscarinic receptor blockade which can increase HR and AV conduction

Vasodilation via Alpha block and possible reflex tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Quinidine used for

A

Orally effective used for many arrhythmias and atrial fibrillation

Need INITIAL DIGITALIZATION to slow AV conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Quinidine adverse affects

A

1) Cinchonism (GI, tinnitus, ocular dysfunction, CNS excitation)
2) Hypotension
3) Prolongation of QRS and increase in QT interval associated with Syncope (torsades)
4) Black water Fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Quinidine drug interactions

A

Hyper K enhances effects and Hypo K decreases affects

Displaces Digoxin from tissue binding sites enhancing toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Procainamide mechanism of action

A

Blocks fast Na channels that are open or activated

Incarease action potential duration and effective refractory period

Blocks K channels

Has less Muscarinic receptor block

Metabolized via N-acetyltransferase to N-acetyl procainamide, an active metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Procainamide used for

A

Antiarrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Procainamide adverse affects

A

SLE - like syndrome in slow acetylators

Hematotoxicity causing thrombocytopenia and agranulocytosis

Torsades

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Class 1A antiarrythmics drugs

A

1) Quinidine
2) Procainamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Class 1A antiarrhythmics MOD

A

1) block fast, active Na Channels
2) Block K channels
3) Some Muscarinic receptor blockade

Increases APD and ERP

Affect Phase 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Disopyramide action

A

Class 1A antiarrythmic with the most M blockade

Not used for arterial arrythmia

Used for VENTRICULAR arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drugs that cause SLE- like disease

A

1) Procainamide
2) Isoniazid
3) Hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lidocaine mechanism of action

A

Block fast Na channels in inactivated state (damaged tissue)

Decrease APD due to block of SLOW Na “window” currents - increases diastole and extends the time for recovery

Give in IV to prevent First Pass metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lidocaine used for

A

Arrythmias due to:

1) post MI
2) Open-heart surgery
3) Digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lidocaine adverse affects

A

CNS toxicity causing seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mexiletine mechanism of action

A

Blocks fast Na channels in inactivated state

Given orally

Same as Lidocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tocainide mechanism of action

A

Blocks fast inactivated Na channels

Same as Lidocaine

Given orally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tocainide adverse affects

A

can lead to agranulocytosis and decrease on other blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Class 1B drugs

A

Lidocaine

Mexiletine

Tocainide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Class 1B drugs Mechanism of action

A

Blocks fast, inactivated Na channels

Blocks slow Na channels

Found in Ischemic tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Flecainide mechanism of action

A

Blocks fast Na channels in His-Purkinje tissue

Has no effect on APD

No ANS effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Flecainide adverse affects

A

can cause sudden death post MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Class 2 drugs

A

Beta blockers:

1) Propranolol (B1=B2)
2) acebutolol (B1)
3) Esmolol (B1 short acting for SVT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Class 2 antiarrythmics mechanism of action

A

Prevent Beta receptor activation decreasing cAMP

Decrease SA and AV nodal activity

Decrease slope of phase 4 (diastolic current) in AP in Pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Amiodarone mechanism of action

A

Decreases K channel slowing phase 3 (repolarization) of AP

Increase APD and ERP

Mimics class 1, 2, 3, and 4 antiarrythmics

Large VD and multiple effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Amiodarone adverse affects

A

1) Pulmonary fibrosis
2) blue pigmentation of the skin (Smurf Skin)
3) Phototoxicity
4) Corneal deposits
5) Hepatic necrosis
6) Thyroid dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Sotalol mechanism of action

A

Decrease conductance of K channels slowing phase 3

Non - selective Beta blockade - Beta 1 leading to decrease HR, AV conduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Sotalol adverse affects

A

Torsades (the worst)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Class 3 drus

A

Amiodarone

Sotalol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Class 3 mechanism of action

A

Block K channels decrease phase 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Verapamil and diltiazem mechanism of action

A

Class 4 antiarrythmics that block Ca Channels

Decrease phae 0 and phase 4

Decrease SA and AV nodal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Verapamil adverse affects

A

1) consitpation
2) dizziness
3) flushing
4) hypotension
5) AV block
6) Gingival hypoplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Diltiazem adverse affects

A

Same as Verapamil minus constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Class 4 drugs

A

Verapamil and Diltiazem

Ca blocks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Class 4 antiarrythmic drug interactions

A

Additive AV block with Beta blockers and Digoxin

Verapamil displaces Digoxin from tissue-binding sites, increasing Digoxin toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How to treat Torsades

A

1) Control HypoK
2) Correct HypoMg
3) Discontinue drug causing prolonged QT
4) attempt to shorten APD with Isoproterenol or electrical paceing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Drugs causing QT prolongation (Torsades)

A

Class 1A and Class 3 drugs

Thioridazine

TCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Adenosine Action

A

Causes Gi coupled decrease in cAMP

Decrease SA and AV nodal activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Adenosine is DOC for

A

Paroxysmal supraventricular tachycardia

AV nodal arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Adenosine adverse affects

A

1) Flushing
2) Sedation
3) Dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Adenosine interaction with Methylxanthines

A

Methyxanthines are Theophylline and caffeine

Adenosine antagonized by Methylxanthines

Methylxanthines will decrease affect of Adenosine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Stratagey for antihypertensives

A

Decrease TPR - CCB

Decrease CO - Beta blockers, CCB

Decrease body fluids - Diuretics, ACEI, ARB

Decrease BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Clonodine and Methyldopa Mechanism of action

A

Alpha 2 agonist that decreases sympathetic outflow

Decreases TPR and HR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Clonodine used for

A

Mild to moderate hypertension

Opiate withdrawl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Methyldopa used for

A

Mild to moderate HT

Hypertensive managment in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Issue with Clonodine

A

Can lead to MASSIVE rebound HT if stopped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Reserpine mechanism of action

A

Decreases presynamptic storage levels decreasing CO and TPR because of decreased Norepi, Dopamine and serotonin in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Reserpine adverse affects

A

Depression (severe leading to suicide)

Edema

Increase GI secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Guanethidine mechanism of action

A

Inhibit NE release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Adverse affects of Alpha 1 blockers used for HT

A

1) First dose syncope (sudden fall of BP)
2) Orthostatic Hypotension
3) Urinary incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Advantages of using Alpha 1 blockers for HT

A

Good for HT and BPH

Increase HDL and Decrease LDL

51
Q

Adverse affects of using Beta blockers in HT

A

1) CVS depression
2) Fatigue
3) Sexual dysfunction
4) Increase LDL and TG
5) mask DM

52
Q

Hydralazine mechanism of action

A

1 for preganancy induced HT

Decrease TPR via arteriolar dilation

Acts through Nitric Oxide

53
Q

Hydralazine adverse affects

A

1) SLE like syndrome in Slow Acetylators
2) Edema
3) Reflex Tachycardia

54
Q

Nitroprusside Mechanism of action

A

Decrease TPR via dilation of both arterioles and venules

DOC for Hypertensive emergencies via IV

Acting through Nitric oxide

55
Q

Nitroprusside adverse affects

A

Causes cyanide toxicity when co-administered with nitrites and thiosulfates

56
Q

Minoxidil mechanism of action

A

Opens K channels causing HYPERPOLARIZATION of smooth muscle results in ARTERIOLAR vasodilation

57
Q

Minoxidil used for

A

1) severe HT
2) Baldness

58
Q

Diazoxide mechanism of action

A

Opens K channels causing HYPERPOLARIZATION of smooth muscles reults in arteriolar vasodilation

59
Q

Diazoxide used for

A

Hypertensive emergencies

60
Q

Adverse affects of Minoxidil

A

1) Hypertrichosis (Hirsturism)
2) Edema
3) Reflex tachycardia

61
Q

Adverse affects of Diazoxide

A

1) hyperglycemia (decrease insulin release)
2) Edema
3) reflex tachycardia

62
Q

Captopril (-Prils) mechanism of action

A

ACE inhibitors

Block formation of AT 2 resulting in prevention of AT1 - receptor stimulation

Decrease aldosterone and vasodilation

63
Q

Losartan (-Sartan) mechanism of action

A

ARB

Blocks AT1 receptors

Same result as ACEIs on BP mechanisms

64
Q

Aliskiren mechanism of action

A

Directly inhibit Renin

65
Q

ACEI, ARB and Aliskiren used for

A

Mild eot moderate HT

Protective of Diabetic nephropathy (ACEI and ARBS)

CHF (ACEI adn ARBS)

66
Q

ACEI, ARB, and Aliskiren Adverse affects

A

1) Dry cough (ACEI)
2) HyperK
3) Acute renal artery stenosis
4) Angioadema

67
Q

PT has HT with Angina give:

A

Beta blockers and CCB

68
Q

PT has HT and Diabetes give

A

ACEIs and ARBs

69
Q

PT has HT and HF give

A

ACEIs, ARBs, and Beta blockers

70
Q

PT has HT and post MI give

A

Beta Blocker

71
Q

PT has HT and BPH give

A

Alpha 1 selective blocker

72
Q

PT has HT and Dyslipidemia give

A

Alpha blocker, CCBs, ACEIs/ARBs

73
Q

Bosentan mechanism of action

A

Endothelin - 1 receptor antagonist inhibiting ETA action of vasoconstriction Used for pulmonary HT

74
Q

Bosentan adverse affects

A

Headache, flushing, hypotension and is contraindicated in pregnancy

75
Q

Epoprostenol mechansim of action and use

A

Prostacyclin (PGI2) analog

Used via infusion pump to treat pulmonary HT

76
Q

Sildenafil mechanism of action

A

Inhibits type V PDE and increases cGMP causing pulmonary artery relaxation and decreases pulmonary HT

77
Q

Goal for treating HF

A
  1. Decrease preload: Diuretics, ACEI, ARB, venodilators
  2. Decrease afterload: ACEI, ARB, arteriodilators
  3. Increase contractility: Digoxin, beta agonist
  4. Decrease remodeling of cardiac muscle: ACEI, ARB, spironolactone, beta blockers
78
Q

Digoxin mechanism of action

A

Inhibition of cardiac Na/K ATPase cuases increas intracellular Na.

Increase in Na decreases Na/Ca exchange causing an increase in intracellular Ca resulting in increase Ca release from Sarcoplasmic reticulum.

Increase in Ca causes increase actin-myosin interaction and increase in contractile force

Also, increase vagal activity resulting in parasympathetic actions

79
Q

Digoxin pharmacokinetics

A

Long t 1/2: needs LD

Cleared by kidneys so take caution in renal failure

Large VD because it binds to tissue, caution in displacement via Verapamil and quinidine

80
Q

Digoxin adverse affects

A
  1. Anorexia, nausea
  2. Prolonged PR
  3. Shortened PT
  4. Depressed ST or inverted Twave
  5. Visual defects, halos
  6. In toxic doses causes: Arrhythmia and heart block
81
Q

Inamrinone and milrinone mechanism of action

A

Phosphodiesterase inhibitors causing Increase in cAMP in heart muslce resulting int increase inotropy and increase cAMP in smooth muscle resulting in decrease TPR

82
Q

Ranolazine mechanism of action

A

Blocks late inward Na current in cardiac myocytes causing decrease in Ca accumulation resulting in decreased end diastolic pressure and improvement of diastolic coronary flow

83
Q

Ranolazine adverse affects

A
  1. Constipation and nausea
  2. Increased QT
84
Q

Acetazolamide mechanism of action

A

Carbonic Anhydrase inhibitor resulting in:

  1. Decrease H formation inside PCT
  2. Decrease Na/H antiport
  3. Increase Na dn HCO3 in lumen
  4. Increase Diuresis
85
Q

Acetazolamide used for

A

Galucoma, Acute mountain sickness, Metabolic Alkalosis

86
Q

Acetazolamide adverse affects

A
  1. Bicaronaturia and acidosis
  2. HypoK
  3. HyperCl
  4. Paresthesias
  5. Renal stones
  6. Sulonamide hypersensitivity
87
Q

Dorzolamide is

A

Similar to Acetazolamide a CA inhibitor Used Topically for Glaucoma

88
Q

Furosemide mechanism of action

A

Loop diuretic inhibiting Na/K/Cl transporter in TAL resulting in:

  1. Decrease intracellular K in TAL
  2. Decrease back diffusion of K
  3. Decrease positive potential
  4. Decrease reabsorption of Ca and Mg
  5. Increase diuresis
89
Q

Furosemide used for

A
  1. Acutue pulomnary edema
  2. HF
  3. HT
  4. Refractory edema
  5. Acute renal faiulre
  6. Anion overdose
  7. HyperCa states
90
Q

Ethacrynic acid is

A

A loop diuretic similar to furosemide with out the sulfonamide allergic reaction. However, causes irreversible ototoxicity

91
Q

Drugs with sulfa allergies

A
  1. CA inhibitors
  2. Furosemide
  3. Thiazides
  4. Sulfa antibiotics
  5. Celecoxib
92
Q

Furosemide adverse affects

A
  1. Sulfa reaction
  2. HypoK and Alkalosis
  3. HypoCa - can cause renal Ca stones
  4. HypoMg
  5. Hyperuricemia
93
Q

Furosimede drug interactions

A

Lithium decreases clearance.

Digoxin in toxicity due to electrolyte disturbances

94
Q

Thiazide mechanism of action

A

Na/Cl transporter inhibition in DCT resulting in:

  1. Increase luminal Na and Cl
  2. Increase diuresis
95
Q

Thiazides used for

A
  1. HT and CHF
  2. Calcium kidney stones
  3. Nephrogenic DI
96
Q

Thiazide adverse affects

A
  1. Sulfa reaction
  2. HypoK and Alkalosis
  3. HyperCa
  4. Hyperuricemia
  5. Hyperglycemia
  6. Hyperlipidemia
97
Q

Indapamide is

A

A thiazide that does not cause Hyperlipidemia

98
Q

Spironolactone mechanism of action

A

K-sparing diuretic that inhibits aldosterone receptors in the basolateral side of Collecting tubules. Causes increase K and decrease Na

99
Q

Spironolactone used for

A
  1. Hyperaldosteronic sstate
  2. Adujunt to K-wasting
  3. Antiandorgenic uses (female hisutism)
  4. CHF
100
Q

Spironolactone adverse affects

A

HyperK and Acidosis

Antiandrogen

101
Q

Eplerenone is

A

A K-sparing that is selective aldosterone receptor blocker

102
Q

Amiloride and mechanism of action

A

Na channel blocker in the luminal area of Collecting tubules

103
Q

Triamterene is

A

Na channel blocker like amiloride

104
Q

Amiloride used for

A

K sparing

Lithium induced nephrogenic DI

105
Q

Amiloride adverse affects

A

HyperK and Acidosis

106
Q

Acetazolamide Urinary Electrolytes

A
  • Increase in Na
  • Increase in K
  • Double increase in HCO

Resulting in Blood ACIDOSIS

107
Q

Furosemide Urinary Electrolytes

A
  • Double increase in Na
  • Increase in K
  • Increase in Ca
  • Increase in Mg
  • Increase in Cl

Resulting in Blood ALKALOSIS

108
Q

Thiazide Urinary Electrolytes

A
  • Increase in Na
  • Increase K
  • Increase Cl
  • Decrease Ca

Resulting in blood ALKALOSIS

109
Q

K-sparing Urinary Electrolytes

A
  • Small Increase in Na
  • Decrease in K

Resulting in Blood ACIDOSIS

110
Q

Lovastatin (-Statins) mechanism of action

A

HMG-CoA reductase inhibition results in:

  1. Decrease liver cholesterol
  2. Increase LDL receptor expression
  3. Decrease plasma LDL
  4. Decrease VLDL synthesis causing Decrease Triglyceridemia

Inhibits conversion of HMC CoA to Mevalonic acid then cholesterol

111
Q

Lovastatin adverse affects

A
  1. Myalgia, Myopathy (check creatine kinase)
  2. Rhabdomyolysis (increase with Gemfibrozil)
  3. Hepatotoxicity (check liver enzymes)
112
Q

Cholestyramine mechanism of action

A

Complexation of bile salts in the gut results in:

  1. Decrease enterohepatic recirculation of bile salts
  2. Increase synthesis of new bile salts by the liver
  3. Decrease liver cholesterol
  4. Increase LDL receptor expression
  5. Decrease blood LDL
113
Q

Colestipol is

A

Same as cholestyramine a bile acid inhibitor

114
Q

Cholestyramine adverse affects

A
  1. Increase VLDL and Triglycerides (contraindicated in Hypertriglyceridemia)
  2. GI disturbance (steatorrhea)
  3. Vit malabsorption
115
Q

Niacin (Vit B3) mechanism of aciton

A

Inhibits VLDL synthesis resulting in:

  1. Decrease plasma VLDL
  2. Decrease plasma LDL
  3. Increase plasma HDL
116
Q

Niacin (Vit B3) adverse affects

A
  1. Flusing, pruritus, burning pain (use asprin)
  2. Hepatotoxicity
117
Q

Gemfibrozil mechanism of action

A

Fibrate that bind to PPARalpha and increase expression of lipoprotein lipase resulting in:

  1. Decrease VLDL and IDL
  2. Modest decrease in LDL
  3. Increase in HDL
118
Q

Fenofibrate is

A

Same as gemfibrozil a fibrate

119
Q

Gemfibrozil adverse affects

A

Cholesterol Gallstones

Myositis

120
Q

Ezetimibe mechanism of action

A

Prevents intestinal absorption of cholesterol resulting in Decrease in LDL

121
Q

Antihyperlipidemics that are used when there is an increase in cholesterol

A
  1. Cholestyramine
  2. Colestipol
  3. Ezetimibe
122
Q

Antihyperlipidemic used when there is increase TG

A
  1. Gemfibrozil
  2. Fenofibrate
123
Q

Antihyperlipidemics used when there is increas in Cholesterol and TG

A
  1. Statins
  2. Niacin
  3. Ezetimibe
124
Q

Orlistat mechanism of action

A

Inhibits pancreatic lipase leading to decreas triglyceride breakdown in intestines

Pharmacology (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions